This is an aggregated industry headline. Read the full story at FierceBiotech →
FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
By FierceBiotech
· Apr 29, 2026
· via FierceBiotech
Image: FierceBiotech
Tags
policyformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
PolicyFiercePharma ↗
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer an…
PolicySTAT News ↗
The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny label…